Institutional shares held 34.9 Million
121K calls
41K puts
Total value of holdings $265M
$914K calls
$311K puts
Market Cap $262M
36,987,600 Shares Out.
Institutional ownership 94.38%
# of Institutions 163


Latest Institutional Activity in QTRX

Top Purchases

Q4 2024
Ameriprise Financial Inc Shares Held: 3.21M ($22.7M)
Q4 2024
William Blair Investment Management, LLC Shares Held: 1.06M ($7.53M)
Q4 2024
Ubs Group Ag Shares Held: 935K ($6.63M)
Q4 2024
Eventide Asset Management, LLC Shares Held: 615K ($4.36M)
Q4 2024
Kent Lake Pr LLC Shares Held: 900K ($6.38M)

Top Sells

Q4 2024
Alliancebernstein L.P. Shares Held: 2.44M ($17.3M)
Q4 2024
Granahan Investment Management, LLC Shares Held: 536K ($3.8M)
Q4 2024
Emerald Advisers, LLC Shares Held: 278K ($1.97M)
Q4 2024
Gilder Gagnon Howe & CO LLC Shares Held: 68.7K ($487K)
Q4 2024
Emerald Mutual Fund Advisers Trust Shares Held: 217K ($1.54M)

About QTRX

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.


Insider Transactions at QTRX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
353K Shares
From 13 Insiders
Exercise of conversion of derivative security 1K shares
Grant, award, or other acquisition 286K shares
Open market or private purchase 66K shares
Sell / Disposition
31K Shares
From 3 Insiders
Open market or private sale 2.5K shares
Payment of exercise price or tax liability 28.5K shares

Track Institutional and Insider Activities on QTRX

Follow Quanterix Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells QTRX shares.

Notify only if

Insider Trading

Get notified when an Quanterix Corp insider buys or sells QTRX shares.

Notify only if

News

Receive news related to Quanterix Corp

Track Activities on QTRX